RankAlpha logo
Back to Rankings

STXS

StereotaxisB
NYSE American / Health Care Equipment & Services
Last Price
At close
2026-06-03
View Chart
Current thesis
The bull case is that STXS now has a clearer strategic catalyst set: it exited 2025 with $13.4 million of cash, reported 2025 revenue of $32.4 million, and has a specific July 2026 window to close the Robocath acquisition, which could broaden its product footprint and reopen a growth narrative if execution is clean [#10-K-2026-03-12] [#8-K-2026-04-15].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Backlog conversion underwhelms and exposes weak demand visibility
Momentum
90
Value
36
Sentiment
50
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.05 · Bull $2.80 · Bear $1.35
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-17 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $4.33
Why
Momentum90 · Δ7d -
Value36 · Δ7d -0.0
Sentiment50 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
90
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
50
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade B. Momentum 90.2 / Value 36.3 / Sentiment 50.1

Fundamentals (TTM)
As of 2026-06-02
Market Cap
$192.54M
Beta
1.44
Shares Out
93.32M
P/E (TTM) · Derived
-6.9
P/S (TTM)
7.32
P/FCF (TTM) · Derived
-21.58
Rev YoY
-18.8%
EPS YoY
+2.9%
Gross Margin
+53.1%
Op Margin
-81.7%
Net Debt
-$12.22M
Current Ratio
1.31
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology